3.60Open3.60Pre Close0 Volume2 Open Interest5.00Strike Price0.00Turnover585.26%IV29.65%PremiumMay 16, 2025Expiry Date3.01Intrinsic Value100Multiplier12DDays to Expiry0.59Extrinsic Value100Contract SizeAmericanOptions Type-0.6202Delta0.1767Gamma0.59Leverage Ratio-0.0327Theta-0.0013Rho-0.37Eff Leverage0.0014Vega
ProQR Therapeutics Stock Discussion
Van Herk Investments 11,461,995 shares, 10.9%
has options
nfa
Singapore, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Webuy Global Ltd. (NASDAQ:WBUY) ("Webuy" or the "Company"), a Southeast Asian community e-commerce innovator, is thrilled to announce the launch of its cutting-edge Travel AI, Micky1.0. This tool, available through WhatsApp, helps simplify travel planning and provides personalized support whenever and wherever it is needed.
With just a WhatsApp number, users can interact with Micky1.0 to get immediate answers to the...
ProQR Therapeutics Announces $8.1 Million in New Funding From Rett Syndrome Research Trust to Expand Rna Editing Collaboration
📊⚡️📊
big offering watchout
NEWS
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical data for its AX-0810 pipelin...
No comment yet